Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.
Kerkelä R, Grazette L, Yacobi R, Iliescu C, Patten R, Beahm C, Walters B, Shevtsov S, Pesant S, Clubb FJ, Rosenzweig A, Salomon RN, Van Etten RA, Alroy J, Durand JB, Force T.
Kerkelä R, et al.
Nat Med. 2006 Aug;12(8):908-16. doi: 10.1038/nm1446. Epub 2006 Jul 23.
Nat Med. 2006.
PMID: 16862153
Free article.